Abstract

Adenylosuccinase (ASase) deficiency provokes accumulation in body fluids of succinyl-adenosine (S-Ado) and SAICAriboside, the dephosphorylated derivatives of the two substrates of the enzyme. The concentration of both compounds reaches about 100 μM in cerebrospinal fluid, i.e. 10- to 20-fold that In plasma. As an attempt to elucidate the mechanisms of the psychomotor retardation, accompanied by autistic features, recorded in ASase deficiency, interference of S-Ado and SAICAriboside with the binding of adenosine (Ado) to its cerebral receptors was investigated. The binding of 1-2.5 nM (2-3H]Ado to a particular fraction of rat cerebral cortex, in the presence of 0.25-1 μ M deoxycoformycin, was diminished by 56 ± 4 % (mean ± SEM, n=6) by unlabelled Ado (2.5-100 μM). Diminution of binding by ligands for A1 receptors was 24 % with 2.5 μM 2-chloroadenosine, 32 % with 25 μM R-N6-phenylisopropyl-Ado (PIA), 29 % with 25 MM N6-cyclo-hexyl-Ado (CHA) and 36 % with 25 μM N6-cyclopentyl-Ado (CPA). 200 μM 5′-N-ethylcarboxamide-Ado (NECA), a ligand for A2 receptor sites, and 100 μM dipyridamole, a ligand for uptake sites, decreased binding by, respectively, 39 and 33 %. In contrast, neither S-Ado nor SAICAriboside, both at up to 200 μM concentrations, influenced the binding of [2-3H]Ado. These results indicate that the psychomotor defects observed in ASase deficiency are probably not due to the occupation of cortical membrane sites for Ado by the succinylpurines.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call